Condition
SCI
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
60.0%-27% vs avg
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
60.0%
-26.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
60% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 2 (1)
Trial Status
Completed3
Terminated2
Recruiting1
Trial Success Rate
60.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07234903Not ApplicableRecruiting
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
NCT03780829Early Phase 1TerminatedPrimary
AIH for Spinal Cord Repair
NCT00860990TerminatedPrimary
VA Gastrointestinal (GI) Quality of Life Survey
NCT00855283Phase 2CompletedPrimary
Intranasal Administration of a Prokinetic for Bowel Evacuation in Persons With SCI
NCT00856648CompletedPrimary
SmartPill Monitoring for Assessment of GI Function in SCI
NCT00627107Not ApplicableCompleted
A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit
Showing all 6 trials